About
Veos Pharmaceuticals is a science-driven cleantech and biotech company developing nature-based solutions for soil regeneration, water purification, and emissions reduction. Our flagship platform, OliQuell™, upcycles olive waste into a mineral-enhanced formulation that reduces CH₄ and H₂S emissions, improves oxygenation, and removes heavy metals and agrochemical residues from water systems.
Headquartered in Madrid and profitable since 2024, Veos Pharma is a MassChallenge finalist and active in collaborations with PepsiCo, Bayer, Syngenta, UPL and leading EU innovation platforms. We hold IP across the EU, US, and Canada, with full regulatory clearance for use in agriculture and wastewater.
We are seeking consortium partners across Horizon Europe and RIV-Circular to scale impact in circular bioeconomy, industrial decarbonization, and climate-smart agri-waste applications.
Area
Circular energy integration: valorising local waste streams for industrial efficiency